These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Extrapyramidal symptoms associated with calcium-channel blockers. Daniel JR; Mauro VF Ann Pharmacother; 1995 Jan; 29(1):73-5. PubMed ID: 7711350 [TBL] [Abstract][Full Text] [Related]
9. [Prophylactic treatment of migraine with flunarizine: 5 mg or 10 mg?]. Cano A; Palomeras E; Sanz P; Fossas P Rev Neurol; 2001 Jul 1-15; 33(1):96. PubMed ID: 11686147 [No Abstract] [Full Text] [Related]
10. Effect of flunarizine, a calcium channel blocker, on intraocular pressure and aqueous humor dynamics in monkeys. Wang RF; Gagliuso DJ; Podos SM J Glaucoma; 2008; 17(1):73-8. PubMed ID: 18303390 [TBL] [Abstract][Full Text] [Related]
11. Effects of the topically applied calcium-channel blocker flunarizine on intraocular pressure in clinically normal dogs. Greller AL; Hoffman AR; Liu C; Ying GS; Vudathala DK; Acland GM; Komáromy AM Am J Vet Res; 2008 Feb; 69(2):273-8. PubMed ID: 18241026 [TBL] [Abstract][Full Text] [Related]
16. [Depression as a side effect of treatment with flunarizine?]. Christensen B; Olesen F; Ostergaard I Ugeskr Laeger; 1988 Nov; 150(46):2827-8. PubMed ID: 3206699 [No Abstract] [Full Text] [Related]
17. [Effects of flunarizine on T-type calcium channels in mouse spermatogenic cells]. Wang CS; Gao XH; Cheng H; Gong W; Zhang XC; Cheng J; Gao R; Xiao H Zhonghua Nan Ke Xue; 2006 Jul; 12(7):594-7, 601. PubMed ID: 16894933 [TBL] [Abstract][Full Text] [Related]